A joint project of the Graduate School, Peabody College, and the Jean & Alexander Heard Library

Title page for ETD etd-03252016-100138


Type of Document Dissertation
Author Nackenoff, Alexander Greer
Author's Email Address anackenoff@gmail.com
URN etd-03252016-100138
Title Determining the Role of Serotonin in Antidepressant Action, as Revealed Utilizing the SERT Met172 Mouse Model
Degree PhD
Department Pharmacology
Advisory Committee
Advisor Name Title
Eugenia Gurevich, Ph.D. Committee Chair
Ariel Deutch, Ph.D. Committee Member
Gregg Stanwood, Ph.D. Committee Member
Randy Blakely Committee Member
Ron Emeson, Ph.D. Committee Member
Keywords
  • SERT
  • Depression
  • I172M
  • SERT Met172
  • ssri
  • serotonin
  • antidepressant
  • serotonin
Date of Defense 2016-03-14
Availability unrestricted
Abstract
The most widely prescribed antidepressant medications are serotonin selective reuptake inhibitors (SSRIs), believed to provide therapeutic benefit by antagonizing the serotonin transporter (5-HT; SERT), which acts to terminate 5-HT synaptic transmission via transport of 5-HT back into the presynaptic neuron. SSRIs are not immediately efficacious in the clinic, even though these drugs are immediately able to increase extracellular 5-HT. SSRIs have been found to interact with a sizable number of non-trivial targets at physiologically relevant concentrations, raising the question whether all of the effects of SSRIs are 5-HT mediated. In order to separate the 5-HT-dependent effects from the off-target effects of SSRIs, I utilize a novel transgenic mouse strain SERT Met172 that confers insensitivity to many SERT blocking drugs in vitro and in vivo, without perturbing normal SERT expression or function. Utilizing behavioral and biochemical assays that are sensitive to acute and chronic SSRI administration, we find that SSRIs require SERT antagonism for actions supporting behavioral sensitivity and hippocampal neurogenesis. These findings provide the most specific analysis to date determining the requirement of SERT antagonism for the antidepressant actions of SSRIs, and that off-target activity is insufficient to produce effects supporting antidepressant efficacy. Through the use of this SERT Met172 mouse model, I also can assess the SERT dependence of mixed action drugs that target SERT. Here, I also describe the efforts to assess the SERT dependence of the mixed action drug vortioxetine, which modulates many 5-HT receptors in addition to SERT antagonism.
Files
  Filename       Size       Approximate Download Time (Hours:Minutes:Seconds) 
 
 28.8 Modem   56K Modem   ISDN (64 Kb)   ISDN (128 Kb)   Higher-speed Access 
  Nackenoff.pdf 3.82 Mb 00:17:41 00:09:06 00:07:57 00:03:58 00:00:20

Browse All Available ETDs by ( Author | Department )

If you have more questions or technical problems, please Contact LITS.